Marksans Pharma Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
178.50 +3.45 (1.97%)Updated : 10 Apr 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -35.57-40.90-15.483.16
Net Changein Cash 92.5120.84176.0394.38
Cash Taxes Paid 125.90122.3563.0172.86
Net Income/ Starting Line 503.97423.53337.65247.51
Total Cash Dividends Paid -27.19-22.66-10.17-10.58
Changesin Working Capital -366.67-248.54-174.48-183.56
Cashfrom Operating Activities 206.66230.41237.4199.26
Cash Interest Paid 2.395.176.074.22
Cashfrom Financing Activities -65.15-68.73197.8379.51
Depreciation/ Depletion 83.3974.2751.8544.78
Other Investing Cash Flow Items Total 123.9168.00-205.58-38.06
Capital Expenditures -172.92-208.84-53.63-46.33
period Type ----
Non- Cash Items -14.02-18.8522.38-9.47
Financing Cash Flow Items -2.39-5.17-6.07-4.22
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -49.01-140.84-259.21-84.39
Issuance( Retirement)of Stock Net -0.00229.5491.16
Foreign Exchange Effects -0.000.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,414.00+23.00(1.65%)
801.40-42.95 (-5.09%)
979.80-40.25 (-3.95%)